FoundationOne CDx is Now FDA Approved as a Diagnostic Tool For ALK+ Non-Small Cell Lung Cancer
source: pixabay.com

FoundationOne CDx is Now FDA Approved as a Diagnostic Tool For ALK+ Non-Small Cell Lung Cancer

FoundationOne CDx is a comprehensive genomic profiling test that is tissue based. It is used to identify individuals diagnosed with ALK+ non-small-cell lung cancer (NSCLC) who will be eligible for…

Continue Reading FoundationOne CDx is Now FDA Approved as a Diagnostic Tool For ALK+ Non-Small Cell Lung Cancer
August is Stevens-Johnson Syndrome Awareness Month: Spreading Rare Disease Awareness
source: pixabay,com

August is Stevens-Johnson Syndrome Awareness Month: Spreading Rare Disease Awareness

The month of August is recognized as Stevens-Johnson Syndrome Awareness Month. The goal of this event is to elevate awareness about Stevens-Johnson syndrome among the general public and in the…

Continue Reading August is Stevens-Johnson Syndrome Awareness Month: Spreading Rare Disease Awareness
New Data Shows Neuroprotective Benefits of ATH434 for MSA
source: pixabay.com

New Data Shows Neuroprotective Benefits of ATH434 for MSA

  In mid-July 2021, biotechnology company Alterity Therapeutics ("Alterity") shared the publication of new data regarding ATH434 for patients with multiple system atrophy (MSA). The data comes from a preclinical…

Continue Reading New Data Shows Neuroprotective Benefits of ATH434 for MSA

Retrospective Study Investigates Safety of Pregnancy in Paroxysmal Nocturnal Hemoglobinuria

A recent study documenting cases of pregnancy in individuals living with paroxysmal nocturnal hemoglobinuria (PNH) was published in the Saudi Journal of Medicine & Medical Sciences. Previously, research on pregnancy with…

Continue Reading Retrospective Study Investigates Safety of Pregnancy in Paroxysmal Nocturnal Hemoglobinuria
China Accepts CAN103 IND for Gaucher Disease
[Source: pixabay.com]

China Accepts CAN103 IND for Gaucher Disease

In a recent news release, rare disease-focused biopharmaceutical company CANbridge Pharmaceuticals Inc. ("CANbridge") shared that the National Medical Products Administration (NMPA) of China accepted an Investigational New Drug (IND) application…

Continue Reading China Accepts CAN103 IND for Gaucher Disease
EC Approves Galafold for Adolescent Fabry Disease with an Amenable Mutation
Source: https://unsplash.com/photos/ZHys6xN7sUE

EC Approves Galafold for Adolescent Fabry Disease with an Amenable Mutation

On August 2, 2021, biotechnology company Amicus Therapeutics ("Amicus") shared that its oral treatment Galafold (migalastat) was approved by the European Commission (EC) for the treatment of adolescent patients (ages…

Continue Reading EC Approves Galafold for Adolescent Fabry Disease with an Amenable Mutation
Technology Allows for Differentiation Between MS and Neuromyelitis Optica Spectrum Disorder Patients with Optic Neuritis
source: pixabay.com

Technology Allows for Differentiation Between MS and Neuromyelitis Optica Spectrum Disorder Patients with Optic Neuritis

A new study published in the journal Scientific Reports has helped explain the differences between neuromyelitis optics spectrum disorder (NMOSD) after optic neuritis (ON) and multiple sclerosis (MS). Although previous studies have…

Continue Reading Technology Allows for Differentiation Between MS and Neuromyelitis Optica Spectrum Disorder Patients with Optic Neuritis
Study of the Week: Undeveloped Microbiota and Epithelial Barriers in Newborns Boost Bacterial Meningitis Risk
source: pixabay.com

Study of the Week: Undeveloped Microbiota and Epithelial Barriers in Newborns Boost Bacterial Meningitis Risk

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Undeveloped Microbiota and Epithelial Barriers in Newborns Boost Bacterial Meningitis Risk

Study Shows How to Better Predict Pacemaker Needs in Myotonic Dystrophy Patients

A recent study has examined what risk factors exist for patients diagnosed with myotonic dystrophy, the most common of all muscular dystrophies. This is a progressive, hereditary condition. Regarding cardiac…

Continue Reading Study Shows How to Better Predict Pacemaker Needs in Myotonic Dystrophy Patients